1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. STOKE THERAPEUTICS INC
Stoke Therapeutics Inc XNAS: STOK
31.07 1.67 (5.68%)
534.9K
XNAS Volume

XNAS 29 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Stoke Therapeutics Inc - STOK - stock price prediction, stock price target, analyst ratings from 10 analysts

Stoke Therapeutics Inc has a share price target of US$ 40, revenue growth forecast of 416.2%, and profit growth estimate of 107.2% for FY25, based on top 10 analyst calls.